Literature DB >> 15099682

Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration.

M H Baumann1, A B Milchanowski, R B Rothman.   

Abstract

It is well established that cocaine stimulates monoamine transmission by blocking reuptake of norepinephrine (NE), dopamine and serotonin into nerve cells, yet few investigations have addressed the effects of chronic cocaine on NE function. In the present study, we examined the effects of repeated cocaine injections on neuroendocrine responses evoked by the alpha2-adrenergic receptor agonist, clonidine. Previous findings show that clonidine increases pituitary growth hormone (GH) secretion by a central mechanism involving postsynaptic alpha2-adrenergic receptors. Male rats previously fitted with indwelling jugular catheters received two daily injections of cocaine (15 mg/kg, i.p.) or saline for 7 days. At 42 h and 8 days after treatment, rats were challenged with clonidine (25 microg/kg, i.v.) or saline, and serial blood samples were withdrawn. Plasma GH and corticosterone levels were measured by radioimmunoassay. Prior cocaine exposure did not affect basal levels of either hormone. However, cocaine-pretreated rats displayed a significant reduction in clonidine-evoked GH secretion at 42 h, and this blunted response was still apparent 8 days later. Corticosterone responses produced by clonidine were similar regardless of pretreatment. The present data suggest that withdrawal from repeated cocaine injections may be accompanied by desensitization of postsynaptic alpha2-adrenoreceptors coupled to GH secretion. Since human patients with depression often exhibit blunted GH responses to clonidine, our findings provide evidence that cocaine withdrawal might produce depressive-like symptoms via dysregulation of NE mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099682     DOI: 10.1016/j.neuroscience.2004.02.013

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors.

Authors:  John R Mantsch; Andy Weyer; Oliver Vranjkovic; Chad E Beyer; David A Baker; Holly Caretta
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

2.  Differential effects of acute and chronic treatment with the α2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys.

Authors:  Stephen J Kohut; Peter A Fivel; Nancy K Mello
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

3.  Sex differences in guanfacine effects on drug craving and stress arousal in cocaine-dependent individuals.

Authors:  Helen C Fox; Peter T Morgan; Rajita Sinha
Journal:  Neuropsychopharmacology       Date:  2014-01-07       Impact factor: 7.853

Review 4.  The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.

Authors:  Helen Fox; Rajita Sinha
Journal:  Adv Pharmacol       Date:  2014

5.  Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways.

Authors:  L K Vaughn; J R Mantsch; O Vranjkovic; G Stroh; M Lacourt; M Kreutter; C J Hillard
Journal:  Neuroscience       Date:  2011-08-16       Impact factor: 3.590

6.  Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats.

Authors:  Deanne M Buffalari; Chelsey K Baldwin; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2012-04-18       Impact factor: 4.530

7.  Norepinephrine and impulsivity: effects of acute yohimbine.

Authors:  Alan C Swann; Marijn Lijffijt; Scott D Lane; Blake Cox; Joel L Steinberg; F Gerard Moeller
Journal:  Psychopharmacology (Berl)       Date:  2013-04-06       Impact factor: 4.530

8.  Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats.

Authors:  C A Rudoy; E J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-04-19       Impact factor: 5.067

Review 9.  Animal models and treatments for addiction and depression co-morbidity.

Authors:  Neil E Paterson; Athina Markou
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

10.  Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat.

Authors:  Shane A Perrine; Imran S Sheikh; Chinwe A Nwaneshiudu; Joseph A Schroeder; Ellen M Unterwald
Journal:  Neuropharmacology       Date:  2007-10-22       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.